[ 1 ] Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016;14(8):e1002533 link1

[ 2 ] Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol 2015;31(1):69–75 link1

[ 3 ] Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu Rev Pathol 2012;7(1):99–122 link1

[ 4 ] Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007;104(34):13780–5 link1

[ 5 ] Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13(10):701–12 link1

[ 6 ] Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, et alMicrobial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011;6(1):e16393 link1

[ 7 ] Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 2015;26:26191.25651997 link1

[ 8 ] Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med 2013;34(1):39–58 link1

[ 9 ] Naseer MI, Bibi F, Alqahtani MH, Chaudhary AG, Azhar EI, Kamal MA, et alRole of gut microbiota in obesity, type 2 diabetes and Alzheimer’s disease. CNS Neurol Disord Drug Targets 2014;13(2):305–11 link1

[10] Azcárate-Peril MA, Sikes M, Bruno-Bárcena JM. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol 2011;301(3):G401–24 link1

[11] Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, et alGut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord 2015;30(3):350–8 link1

[12] Panzer AR, Lynch SV. Influence and effect of the human microbiome in allergy and asthma. Curr Opin Rheumatol 2015;27(4):373–80 link1

[13] Roume H, Muller EE, Cordes T, Renaut J, Hiller K, Wilmes P. A biomolecular isolation framework for eco-systems biology. ISME J 2013;7(1):110–21 link1

[14] Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, et alMetabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009;106(10):3698–703 link1

[15] Heintz-Buschart A, May P, Laczny CC, Lebrun LA, Bellora C, Krishna A, et alIntegrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nat Microbiol 2016;2:16180 link1

[16] Fritz JV, Desai MS, Shah P, Schneider JG, Wilmes P. From meta-omics to causality: experimental models for human microbiome research. Microbiome 2013;1(1):14 link1

[17] Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M, Heikenwalder M, et alReversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010;328(5986):1705–9 link1

[18] Parlesak A, Haller D, Brinz S, Baeuerlein A, Bode C. Modulation of cytokine release by differentiated CACO-2 cells in a compartmentalized coculture model with mononuclear leucocytes and nonpathogenic bacteria. Scand J Immunol 2004;60(5):477–85 link1

[19] Nguyen TLA, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research? Dis Model Mech 2015;8(1):1–16 link1

[20] Arnold JW, Roach J, Azcarate-Peril MA. Emerging technologies for gut microbiome research. Trends Microbiol 2016;24(11):887–901 link1

[21] Sung JH, Yu J, Luo D, Shuler ML, March JC. Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model. Lab Chip 2011;11(3):389–92 link1

[22] Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 2012;12(12):2165–74 link1

[23] Kim HJ, Li H, Collins JJ, Ingber DE. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci USA 2016;113(1):E7–15 link1

[24] Marzorati M, Vanhoecke B, De Ryck T, Sadaghian Sadabad M, Pinheiro I, Possemiers S, et alThe HMI? module: a new tool to study the host-microbiota interaction in the human gastrointestinal tract in vitro. BMC Microbiol 2014;14:133 link1

[25] Shah P, Fritz JV, Glaab E, Desai MS, Greenhalgh K, Frachet A, et alA microfluidics-based in vitro model of the gastrointestinal human-microbe interface. Nat Commun 2016;7:11535 link1

[26] Roume H, Muller EE, Cordes T, Renaut J, Hiller K, Wilmes P. A biomolecular isolation framework for eco-systems biology. ISEM J 2013;7(1):110–21 link1

[27] Sheridan WG, Lowndes RH, Young HL. Intraoperative tissue oximetry in the human gastrointestinal tract. Am J Surg 1990;159(3):314–9 link1

[28] Schmidt TM, Kao JY. A little O2 may go a long way in structuring the GI microbiome. Gastroenterology 2014;147(5):956–9 link1

[29] Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9(5):313–23 link1

[30] Lee PJ, Hung PJ, Lee LP. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol Bioeng 2007;97(5):1340–6 link1

[31] Jang KJ, Suh KY. A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. Lab Chip 2010;10:36–42 link1

[32] Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science 2010;328(5986):1662–8 link1